Is Molina Healthcare, Inc. (MOH) Overvalued?
We dive into why Molina Healthcare, Inc. (MOH) could be considered overvalued on 2026-07-23, based on AAII’s Value Score and Grade.Tudor Pop
Stock Evaluator: Molina Healthcare, Inc. (MOH)
Molina Healthcare, Inc. MOH
$202.32
5.38
2.73%
August 21, 2026 11:24:57 AM
EST
Volume: 117,502
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.
Commentary & Analysis
Why Molina Healthcare, Inc.’s (MOH) Stock Is Down 12.62%
As of Thursday, July 23, Molina Healthcare, Inc.’s MOH share price has dipped by 12.62%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Molina Healthcare, Inc.’s (MOH) Stock Is Down 6.82%
As of Thursday, July 23, Molina Healthcare, Inc.’s MOH share price has dipped by 6.82%, which has investors questioning if this is right time to buy.Michael Rose
What You Need to Know About Molina Healthcare, Inc.'s Q3 Earnings
Molina Healthcare, Inc.'s fiscal Q3 earnings report was released on Wednesday, July 22. Let's dive in to see if (MOH) missed or beat analyst's expectations.Jenna Brashear
Why Molina Healthcare, Inc.’s (MOH) Stock Is Up 5.15%
As of Thursday, June 25, Molina Healthcare, Inc.’s MOH share price has surged by 5.15%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | MOH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,258.8 | $1,982.5 | 78% |
|
| Shares Out (Mil) | 51.3 | 77.7 | 48% |
|
| Institutional Ownership | 95.5% | 86.1% | 67% |
|
| Float (Mil) | 45.9 | 52.1 | 45% |
|
| Beta | 0.74 | 0.75 | 44% |
|
| Avg Daily Volume (000s) | 539 | 637 | 59% |
|
| Price Change (52-week) |
13.3% | 79.7% | 56% |
|
| Growth | MOH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 18.8% | 10.9% | 79% |
|
| Net Income (5yr) | (6.8%) | (1.6%) | 32% |
|
| EPS (5yr) | (4.5%) | 0.3% | 26 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.7%) | (17.9%) | 39% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 18 | 19 | 19 | |
| Current EPS | $0.830 | $5.242 | $9.740 | |
| Month Ago EPS | $1.268 | $5.160 | $9.295 | |
| # Rev Up | 0 | 2 | 2 | |
| # Rev Down | 2 | 0 | 0 | |
| Three Months Ago EPS | $1.305 | $5.208 | $9.168 | |
| Year/Year Chg | (29.3%) | (41.2%) | 53.1% | |
| Financials | MOH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $42,469 | $1,504 | 96% |
|
| Net Income (TTM) (Mil) | ($7) | $28 | 32% |
|
| EPS (TTM) | ($0.137) | $0.200 | 35% |
|
| Operating Cash Flow (TTM) (Mil) | $365 | $162 | 67% |
|
| Net Cash Flow (TTM) (Mil) | $501 | $9 | 91% |
|
| Long-Term Debt (Q1) (Mil) | $3,953 | $338 | 83% |
|
| Enterprise Value (Q1) (Mil) | $9,259 | $2,416 | 72% |
|
| Valuation | MOH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.46 | 2.79 | 58% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | MOH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 8.4% | 27.8% | 8% |
|
| Net Margin | 0.0% | 1.2% | 32% |
|
| ROA | 0.0% | 2.2% | 39% |
|
| ROE | (0.2%) | 7.2% | 35% |
|
| Liabilities to Assets | 73.9% | 58.6% | 69% |
|
| F-Score | 4 | 5 | 34% |
|
Molina Healthcare, Inc. did not pass any screens on 8/20/2026.
